story of the week
Circulating Tumor DNA Analyses as Prognostic Markers for Stage III Colon Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
JAMA Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Circulating Tumor DNA Analyses as Markers of Recurrence Risk and Benefit of Adjuvant Therapy for Stage III Colon Cancer
JAMA Oncol 2019 Oct 17;[EPub Ahead of Print], J Tie, JD Cohen, Y Wang, M Christie, K Simons, M Lee, R Wong, S Kosmider, S Ananda, J McKendrick, B Lee, JH Cho, I Faragher, IT Jones, J Ptak, MJ Schaeffer, N Silliman, L Dobbyn, L Li, C Tomasetti, N Papadopoulos, KW Kinzler, B Vogelstein, P GibbsFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.